Industry Backs FDA Guidance on Patient-Focused Drug Development
- Biotechnology and pharmaceutical stakeholders largely supported guidance from the FDA on patient-focused drug development, but some sought some clarification about FDA decision-making. The agency held a public workshop last December to inform the development of the fourth draft guidance to come out under the patient-focused drug development program...
